CIBC Bancorp USA’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Buy
2,169
+156
+8% +$22.6K ﹤0.01% 1458
2026
Q1
$238K Buy
+2,013
New +$264K ﹤0.01% 1526
2025
Q3
$386K Buy
+3,850
New +$458K ﹤0.01% 979

Other funds holding NOVT

CIBC Bancorp USA's NOVT Position: Q2 2026 in Review

CIBC Bancorp USA increased its Novanta (NOVT) stake by 7.7% in Q2 2026, buying an estimated $22.6K and bringing the position to 2,169 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

CIBC Bancorp USA first reported a position in NOVT in Q3 2025 and has held it in 3 quarters since. The position peaked at $386K in Q3 2025. 361 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • CIBC Bancorp USA held 2,169 shares of Novanta worth $352K as of Q2 2026.
  • CIBC Bancorp USA bought 156 Novanta shares in Q2 2026, an estimated $22.6K.
  • Novanta made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1458 holding.
  • CIBC Bancorp USA first reported a position in Novanta in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Novanta position peaked at $386K in Q3 2025.
  • 361 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.